1. Home
  2. SRRK vs NCNO Comparison

SRRK vs NCNO Comparison

Compare SRRK & NCNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • NCNO
  • Stock Information
  • Founded
  • SRRK 2012
  • NCNO 2011
  • Country
  • SRRK United States
  • NCNO United States
  • Employees
  • SRRK N/A
  • NCNO N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • NCNO Computer Software: Prepackaged Software
  • Sector
  • SRRK Health Care
  • NCNO Technology
  • Exchange
  • SRRK Nasdaq
  • NCNO Nasdaq
  • Market Cap
  • SRRK 3.2B
  • NCNO 2.6B
  • IPO Year
  • SRRK 2018
  • NCNO 2020
  • Fundamental
  • Price
  • SRRK $34.04
  • NCNO $26.45
  • Analyst Decision
  • SRRK Strong Buy
  • NCNO Buy
  • Analyst Count
  • SRRK 6
  • NCNO 16
  • Target Price
  • SRRK $42.17
  • NCNO $31.13
  • AVG Volume (30 Days)
  • SRRK 1.3M
  • NCNO 1.8M
  • Earning Date
  • SRRK 08-07-2025
  • NCNO 05-28-2025
  • Dividend Yield
  • SRRK N/A
  • NCNO N/A
  • EPS Growth
  • SRRK N/A
  • NCNO N/A
  • EPS
  • SRRK N/A
  • NCNO N/A
  • Revenue
  • SRRK N/A
  • NCNO $556,707,000.00
  • Revenue This Year
  • SRRK N/A
  • NCNO $9.59
  • Revenue Next Year
  • SRRK $502.60
  • NCNO $8.53
  • P/E Ratio
  • SRRK N/A
  • NCNO N/A
  • Revenue Growth
  • SRRK N/A
  • NCNO 13.39
  • 52 Week Low
  • SRRK $6.76
  • NCNO $18.75
  • 52 Week High
  • SRRK $46.98
  • NCNO $43.20
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 55.54
  • NCNO 51.18
  • Support Level
  • SRRK $30.97
  • NCNO $26.69
  • Resistance Level
  • SRRK $37.00
  • NCNO $27.29
  • Average True Range (ATR)
  • SRRK 2.05
  • NCNO 0.67
  • MACD
  • SRRK 0.23
  • NCNO -0.14
  • Stochastic Oscillator
  • SRRK 65.40
  • NCNO 40.36

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

Share on Social Networks: